|
AU2012202039A1
|
|
Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
|
|
WO2009063364A2
|
|
Modulators of urotensin receptor and methods of use thereof
|
|
WO2009053895A2
|
|
Quinoline urotensin-ii receptor antagonists
|
|
AU2008306533A1
|
|
Thiophene-2-carboxamide derivatives as modulators of CCR9 receptor
|
|
CN102137655A
|
|
Formulations of N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide
|
|
WO2008112241A1
|
|
Methods an compositions for treatment of an interstitial lung disease
|
|
MX2009006812A
|
|
Modulators of c3a receptor and methods of use thereof.
|
|
EP2069323A1
|
|
Processes for the preparation of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide
|
|
WO2008019074A1
|
|
Processes for the preparation of 4-chloro-3-methyl-5-(2-(2-(6-methylbenzo[d][1,3]dioxol-5-yl)acetyl)-3-thienylsulfonamido) isoxazole
|
|
CN101501017A
|
|
Processes for the preparation of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino}sulfonyl}-2-thiophenecarboxamide
|
|
BRPI0715174A2
|
|
N- (2-acethyl-4,6-dimethylphenyl) -2 - {[(3,4-dimethyl-5-isoxazolyl) -amino] sulphonyl} -2-thiophenocarboxamide polymorphes
|
|
WO2007149568A2
|
|
N- (4-chl0r0-3-methyl-5-is0xaz0lyl) -2- [2-methyl-4, 5- (methylenedioxy) phenylacetyl] -thiophene-3-sulfonamide
|
|
EP2037912A2
|
|
Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
|
|
KR20080106926A
|
|
Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4,5-(methylenedioxy)phenylacetyl]thiophene-3-sulfonamide, sodium salt
|
|
CA2644784A1
|
|
Formulations of sitaxsentan sodium
|
|
AU2007225139A1
|
|
Methods and compositions for treatment of diastolic heart failure
|
|
CN101072564A
|
|
Endothelin a receptor (eta) antagonists in combination with phosphodiesterase 5 inhibitors (pde5) and uses thereof
|
|
US7320989B2
|
|
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
|
US7288538B2
|
|
Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
|
|
CA2517166A1
|
|
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists
|
